WebJan 1, 2012 · Cyclosporin A (CsA) causes a number of clinically relevant drug-drug interactions (DDIs) by inhibiting OATP1B1 and OATP1B3. In the present study, long … WebJun 2, 2010 · CsA inhibited OATP1B1 mediated uptake of atorvastatin about 90-fold more efficiently than Tac, with half maximal inhibitory concentration (IC 50) values of 0.021 ± 0.004 µM and 1.99 ± 0.42 µM, respectively. Co-incubation as compared with pre-incubation with CsA showed a 20-fold lower inhibitory capacity, with an IC 50 value of 0.47 ± 0.34 µM.
Cyclosporine A, but not tacrolimus, shows relevant inhibition …
WebThis medication is given by injection into a vein as directed by your doctor, usually once daily over 2 to 6 hours. The dosage is based on your weight, medical condition, lab tests, and response to... Weboatp1b1-3 inhibitors/brincidofovir ; immunosuppressives; immunomodulators/ponesimod ; ... moderate and weak cyp3a4 inhibitors/tacrolimus ; moderate cyp2c8 inhibitors/selexipag ; guard tronics
Combined Therapy with Atorvastatin and Calcineurin Inhibitors: …
WebAt an equimolar substrate-inhibitor concentration of 10 µM, 212 and 139 molecules were identified as OATP1B1 and OATP1B3 inhibitors, respectively (minimum 50% inhibition). … WebSimeprevir. A direct-acting antiviral agent that inhibits HCV NS3/4A protease to treat chronic hepatitis C virus (HCV) infection in adults with HCV genotype 1 or 4. Ginsenoside Rb1. Ginsenosides are a class of steroid glycosides, and triterpene saponins, found exclusively in the plant genus Panax (ginseng). WebStructure-based identification of OATP1B1/3 inhibitors Several recent studies show that inhibition of the hepatic transport proteins organic anion-transporting polypeptide 1B1 (OATP1B1) and 1B3 (OATP1B3) can result in clinically relevant drug-drug interactions (DDI). guard tx100p husha